Related Experiment Video
Updated: Aug 16, 2026
Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
Published on: December 15, 2023
The regulatory network of Mfsd2a in cerebral ischemia: a novel time-targeted intervention framework
Zhidong He1, Li Zhang2, Jing Sun3
1Department of Neurosurgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun, 130031, Jilin, China.
Abstract:
Cerebral ischemia‒reperfusion injury disrupts blood-brain barrier (BBB) integrity, a process strongly linked to the downregulation of the lipid transporter Mfsd2a. Prior research has focused on the consequences of Mfsd2a loss; however, a systematic synthesis of its upstream regulatory network is lacking. Here, we propose an integrated "Layered and Phased" (L&P) regulatory model as a new conceptual framework in which acute/hyperacute suppression is driven by rapid stress‑responsive transcription factors and microRNAs, while sustained silencing in the subacute/repair phase (days to weeks) may be consolidated by durable epigenetic reprogramming and potentially modulated by dynamic ceRNA networks. We categorized the evidence supporting each mechanism as strong (directly validated in cerebral ischemia models), preliminary (correlative or extrapolated), or predicted/hypothesized (bioinformatics-based). Based on this model, we propose phase‑specific therapeutic strategies, discuss major translational challenges, and outline how this framework can guide biomarker discovery and patient stratification. This L&P framework presents testable hypotheses regarding phase-dependent regulating switches. We outlined the key experiments required to validate the model and discussed their potential to guide biomarker discovery and time-targeted intervention.
Insights
Cerebral ischemia‒reperfusion injury downregulates Mfsd2a, disrupting the blood-brain barrier (BBB). This study proposes a Layered and Phased (L&P) model to explain Mfsd2a regulation, guiding new therapeutic strategies.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Cerebral ischemia-reperfusion injury compromises blood-brain barrier (BBB) integrity.
- This disruption is associated with reduced expression of the lipid transporter Mfsd2a.
- Existing research primarily examines Mfsd2a loss consequences, lacking a comprehensive view of its upstream regulation.
Purpose of the Study:
- To propose a novel "Layered and Phased" (L&P) regulatory model for Mfsd2a.
- To systematically synthesize the upstream regulatory network of Mfsd2a in the context of cerebral ischemia.
- To identify phase-specific therapeutic targets and strategies.
Main Methods:
- Development of the L&P regulatory model integrating transcription factors, microRNAs, epigenetic reprogramming, and ceRNA networks.
- Categorization of supporting evidence into strong, preliminary, and predicted/hypothesized.
- Bioinformatics-based analysis and literature synthesis.
Main Results:
- The L&P model posits distinct regulatory mechanisms for acute (stress-responsive factors) and sustained (epigenetic reprogramming) Mfsd2a suppression.
- Evidence supporting each regulatory mechanism was systematically categorized.
- The model provides a framework for understanding Mfsd2a regulation across different phases of injury.
Conclusions:
- The L&P framework offers testable hypotheses for phase-dependent regulatory switches of Mfsd2a.
- This model can guide the discovery of biomarkers and the development of time-targeted interventions for cerebral ischemia.
- Phase-specific therapeutic strategies are proposed based on the L&P model.
